Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,421 public trials 1,034 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia

NCT02011945

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Winship Cancer Institute Atlanta, Georgia, United States
  • Dana Farber Cancer Institute. Boston, Massachusetts, United States
  • Ut Southwestern Medical Center At Dallas Dallas, Texas, United States
  • The University Of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)

NCT02892318

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • City of Hope Duarte, California, United States
  • Yale University New Haven, Connecticut, United States
  • The NewYork-Presbyterian Hospital Columbia University Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation

NCT01744665

Conditions
Bone Marrow Diseases, CML, Chronic Disease, +11 more
Locations
  • University of Alabama Comprehensive Cancer Center University of Alabama (8) Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Banner MD Anderson (2) Gilbert, Arizona, United States
  • Scottsdale Healthcare/TGen Clinical Research Service SC Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
View all 54 locations
View Trial Details

Related conditions